Edgewise Therapeutics, Inc. ($EWTX)
Filing Information
| Accession Number | 0001191702-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 14, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
127,514
Total Value
$219,822.65
P&L
+inf% (+$4,306,575.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
General Counsel | Common Stock | โ | Aug 12, 2026 | Exercise/Conversion | 5,781 | $0.00 | $0.00 | 15,995 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Aug 12, 2026 | Exercise/Conversion | 6,718 | $0.00 | $0.00 | 22,713 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Aug 12, 2026 | Sale | 2,439 | $43.81 | $106,847.96 | 20,274 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Aug 12, 2026 | Sale | 59 | $44.41 | $2,620.44 | 20,215 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Aug 12, 2026 | Sale | 99 | $44.50 | $4,405.69 | 20,116 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Aug 12, 2026 | Sale | 2,419 | $43.80 | $105,948.57 | 17,697 | Direct | โ | View Details | |
General Counsel | Restricted Stock Units | Derivative | Aug 12, 2026 | Exercise/Conversion | 5,781 | $0.00 | $0.00 | 11,563 | Direct | โ | View Details | |
General Counsel | Restricted Stock Units | Derivative | Aug 12, 2026 | Exercise/Conversion | 6,718 | $0.00 | $0.00 | 20,157 | Direct | โ | View Details | |
General Counsel | Restricted Stock Units | Derivative | Aug 12, 2026 | Grant/Award | 32,500 | $0.00 | $0.00 | 32,500 | Direct | โ | View Details | |
General Counsel | Stock Option (Right to Buy) | Derivative | Aug 12, 2026 | Grant/Award | 65,000 | $0.00 | $0.00 | 65,000 | Direct | โ | View Details |